Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00362375 · ClinicalTrials.gov registry record · Phase 1
Evaluation of the Healthy Love Workshop, an HIV Prevention Intervention for African American Women
A Phase 1 study of HIV Infections and Sexually Transmitted Infections, sponsored by Centers for Disease Control and Prevention.
- Completed
- Registry status
- Phase 1
- Development phase
- 313
- Enrollment target
- 1
- Study location
NCT00362375 is a Phase 1 study of HIV Infections and Sexually Transmitted Infections that has completed, run by Centers for Disease Control and Prevention. The registered enrollment target is 313 participants, below the 445-participant average among 542 other HIV Infections trials with a reported enrollment target (30% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00362375, a Phase 1 study of HIV Infections and Sexually Transmitted Infections, has completed, sponsored by Centers for Disease Control and Prevention.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 313 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this program evaluation is to determine whether the Health Love Workshop, a group-level HIV behavioral intervention, reduces HIV-related sex risk behaviors and increases HIV protective behaviors of African American women and women of African descent. The intent of this program is to support an evaluation of the efficacy of the intervention and to provide feedback to the implementing organization to increase intervention effectiveness.
Conditions Studied
Interventions
- BEHAVIORAL Healthy Love Workshop
- BEHAVIORAL HIV/AIDS 101 Workshop
Study Locations (1)
Georgia
- SisterLove, Inc. - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 313 participants |
| Start Date | 2006-05 |
| Est. Completion | 2008-04 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00362375
The ClinicalTrials.gov registry entry for NCT00362375 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 313 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 445-participant average among 542 other HIV Infections trials with a reported enrollment target (30% lower). The listed sponsor is Centers for Disease Control and Prevention, which has 139 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with HIV Infections appearing as the primary indexed condition, and to 2 interventions - of which Healthy Love Workshop is the first listed.
NCT00362375 reports 1 study location spanning 1 distinct geographic area - top geographies include Georgia.
Frequently Asked Questions
What is clinical trial NCT00362375 about?
NCT00362375 is a clinical study titled "Evaluation of the Healthy Love Workshop, an HIV Prevention Intervention for African American Women". The purpose of this program evaluation is to determine whether the Health Love Workshop, a group-level HIV behavioral intervention, reduces HIV-related sex risk behaviors and increases HIV protective behaviors of African American women and women of African descent. The intent of this program is to s...
What is the current status of trial NCT00362375?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 313 participants. The study started on 2006-05. Estimated completion is 2008-04.
What conditions does trial NCT00362375 study?
This clinical trial studies the following conditions: HIV Infections, Sexually Transmitted Infections.
What interventions are being tested in trial NCT00362375?
The interventions under investigation include: Healthy Love Workshop (BEHAVIORAL), HIV/AIDS 101 Workshop (BEHAVIORAL).
Who is sponsoring clinical trial NCT00362375?
This trial is sponsored by Centers for Disease Control and Prevention, which has 139 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00362375 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV Infections
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
CAR-T Cells for HIV Infection
RECRUITING · Phase 1
-
A Study to Investigate the Use of VH3810109 With or Without Fostemsavir (FTR) to Reduce the Size and Activity of the Viral Reservoir in People Living With HIV
RECRUITING · Phase 1
-
Clinical Trial to Evaluate the Safety and Immunogenicity of Hiltonol, Poly-ICLC-adjuvanted CD40.HIVRI.Env (VRIPRO) in Adult Participants Who Previously Participated in HVTN 706
RECRUITING · Phase 1
-
Pharmacokinetics, Safety, Tolerability of Dolutegravir/Rilpivirine in Pediatrics
RECRUITING · Phase 1
-
A Study to Investigate Pharmacokinetics, Safety and Tolerability of Long-Acting Cabotegravir Plus Recombinant Human Hyaluronidase PH20 in Healthy Adult Participants
RECRUITING · Phase 1
-
First Time in Human Study of Long Acting VH4524184 Formulations
RECRUITING · Phase 1
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.